Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Rheumatol. doi: /nrrheum

Published byBritton Maurice Fisher Modified over 5 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Rheumatol. doi: /nrrheum"— Presentation transcript:

1 Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2017.185
Figure 2 Different approaches for identifying individuals at risk of developing rheumatoid arthritis Figure 2 | Different approaches for identifying individuals at risk of developing rheumatoid arthritis. This figure presents the different phases of rheumatoid arthritis (RA) development proposed by the EULAR study group13, in relation to the possible types of prevention (primary, secondary or tertiary). In addition, it illustrates the risk of RA development for different groups of individuals identified in different settings, and the relative sizes of these groups. Not all patients will pass through every phase of RA development and some phases can be present at the same time (for example, smoking, autoimmunity and arthralgia). FDR, first-degree relative; CSA, clinically suspect arthralgia; MSK, musculoskeletal; UA, undifferentiated arthritis. van Steenbergen, H. W. et al. (2017) Preventing progression from arthralgia to arthritis: targeting the right patients Nat. Rev. Rheumatol. doi: /nrrheum

Download ppt "Nat. Rev. Rheumatol. doi: /nrrheum"

Similar presentations

Risk Factors for Rheumatoid Arthritis

Risk Factors for Rheumatoid Arthritis
Figure 1 Lymphocytes during the disease

Figure 1 Lymphocytes during the disease
Risk Factors for Rheumatoid Arthritis

Risk Factors for Rheumatoid Arthritis
Figure 4 Tissue infiltration and lymphadenopathy in patients with CTLA4 mutations Figure 4 | Tissue infiltration and lymphadenopathy in patients with CTLA4.

Figure 4 Tissue infiltration and lymphadenopathy in patients with CTLA4 mutations Figure 4 | Tissue infiltration and lymphadenopathy in patients with CTLA4.
of different experimental arthritis models

of different experimental arthritis models
Figure 3 Example of how a noncoding regulatory rheumatoid

Figure 3 Example of how a noncoding regulatory rheumatoid
Figure 1 Historical evolution of the clinical classification and

Figure 1 Historical evolution of the clinical classification and
Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.

Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Grip strength across the lifecourse

Figure 1 Grip strength across the lifecourse
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 Enthesitis versus synovitis

Figure 1 Enthesitis versus synovitis
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 4 Simplified T cell and antigen presenting

Figure 4 Simplified T cell and antigen presenting
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Targeted versus untargeted metabolomics approaches

Figure 2 Targeted versus untargeted metabolomics approaches
Figure 1 Metabolic profiling as a tool for studying rheumatic diseases

Figure 1 Metabolic profiling as a tool for studying rheumatic diseases
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum

Similar presentations

Ads by Google